nodes	percent_of_prediction	percent_of_DWPC	metapath
Secobarbital—CYP1A2—Betaxolol—glaucoma	0.0962	0.264	CbGbCtD
Secobarbital—CYP2C9—Diclofenamide—glaucoma	0.0763	0.209	CbGbCtD
Secobarbital—CYP2C9—Dorzolamide—glaucoma	0.0737	0.202	CbGbCtD
Secobarbital—CYP2C9—Methazolamide—glaucoma	0.0657	0.18	CbGbCtD
Secobarbital—CYP1A2—Clonidine—glaucoma	0.0527	0.145	CbGbCtD
Secobarbital—Ataxia—Acetazolamide—glaucoma	0.00375	0.00628	CcSEcCtD
Secobarbital—Tension—Diclofenamide—glaucoma	0.0037	0.00619	CcSEcCtD
Secobarbital—Nightmare—Clonidine—glaucoma	0.00367	0.00614	CcSEcCtD
Secobarbital—Dermatitis exfoliative—Pilocarpine—glaucoma	0.00366	0.00613	CcSEcCtD
Secobarbital—Nervousness—Diclofenamide—glaucoma	0.00366	0.00613	CcSEcCtD
Secobarbital—Thinking abnormal—Betaxolol—glaucoma	0.00362	0.00605	CcSEcCtD
Secobarbital—Anxiety—Metipranolol—glaucoma	0.00351	0.00588	CcSEcCtD
Secobarbital—Syncope—Carteolol—glaucoma	0.00344	0.00575	CcSEcCtD
Secobarbital—Respiratory failure—Betaxolol—glaucoma	0.00337	0.00564	CcSEcCtD
Secobarbital—Loss of consciousness—Carteolol—glaucoma	0.00337	0.00564	CcSEcCtD
Secobarbital—Syncope—Carbachol—glaucoma	0.0033	0.00552	CcSEcCtD
Secobarbital—Syncope—Levobunolol—glaucoma	0.00325	0.00544	CcSEcCtD
Secobarbital—Loss of consciousness—Carbachol—glaucoma	0.00323	0.00541	CcSEcCtD
Secobarbital—Nightmare—Betaxolol—glaucoma	0.0032	0.00535	CcSEcCtD
Secobarbital—Depressed level of consciousness—Betaxolol—glaucoma	0.0032	0.00535	CcSEcCtD
Secobarbital—Loss of consciousness—Levobunolol—glaucoma	0.00318	0.00533	CcSEcCtD
Secobarbital—Bradycardia—Apraclonidine—glaucoma	0.00314	0.00526	CcSEcCtD
Secobarbital—Confusional state—Diclofenamide—glaucoma	0.0031	0.00519	CcSEcCtD
Secobarbital—Shock—Carteolol—glaucoma	0.00308	0.00515	CcSEcCtD
Secobarbital—Somnolence—Metipranolol—glaucoma	0.003	0.00502	CcSEcCtD
Secobarbital—Confusional state—Levobunolol—glaucoma	0.00298	0.00499	CcSEcCtD
Secobarbital—Shock—Carbachol—glaucoma	0.00295	0.00494	CcSEcCtD
Secobarbital—Hypotension—Carteolol—glaucoma	0.00292	0.00489	CcSEcCtD
Secobarbital—Shock—Levobunolol—glaucoma	0.00291	0.00487	CcSEcCtD
Secobarbital—Mental disability—Betaxolol—glaucoma	0.00287	0.00481	CcSEcCtD
Secobarbital—Confusional state—Methazolamide—glaucoma	0.00286	0.00478	CcSEcCtD
Secobarbital—Hypotension—Carbachol—glaucoma	0.00281	0.0047	CcSEcCtD
Secobarbital—Hypotension—Levobunolol—glaucoma	0.00276	0.00462	CcSEcCtD
Secobarbital—Respiratory failure—Timolol—glaucoma	0.00275	0.00461	CcSEcCtD
Secobarbital—Somnolence—Diclofenamide—glaucoma	0.00274	0.00458	CcSEcCtD
Secobarbital—Bradycardia—Brimonidine—glaucoma	0.0027	0.00451	CcSEcCtD
Secobarbital—Tension—Apraclonidine—glaucoma	0.00264	0.00441	CcSEcCtD
Secobarbital—Constipation—Diclofenamide—glaucoma	0.00263	0.0044	CcSEcCtD
Secobarbital—Nightmare—Timolol—glaucoma	0.00261	0.00437	CcSEcCtD
Secobarbital—Nervousness—Apraclonidine—glaucoma	0.00261	0.00437	CcSEcCtD
Secobarbital—Bradycardia—Dorzolamide—glaucoma	0.00258	0.00431	CcSEcCtD
Secobarbital—Bradycardia—Travoprost—glaucoma	0.00256	0.00429	CcSEcCtD
Secobarbital—Tension—Bimatoprost—glaucoma	0.00256	0.00428	CcSEcCtD
Secobarbital—Feeling abnormal—Diclofenamide—glaucoma	0.00254	0.00424	CcSEcCtD
Secobarbital—Bradycardia—Brinzolamide—glaucoma	0.00253	0.00424	CcSEcCtD
Secobarbital—Nervousness—Bimatoprost—glaucoma	0.00253	0.00423	CcSEcCtD
Secobarbital—Somnolence—Methazolamide—glaucoma	0.00252	0.00421	CcSEcCtD
Secobarbital—Hallucination—Dorzolamide—glaucoma	0.00252	0.00421	CcSEcCtD
Secobarbital—Hypersensitivity—Metipranolol—glaucoma	0.00249	0.00416	CcSEcCtD
Secobarbital—Feeling abnormal—Levobunolol—glaucoma	0.00244	0.00408	CcSEcCtD
Secobarbital—Bradycardia—Pilocarpine—glaucoma	0.00243	0.00407	CcSEcCtD
Secobarbital—Body temperature increased—Diclofenamide—glaucoma	0.00243	0.00407	CcSEcCtD
Secobarbital—Syncope—Apraclonidine—glaucoma	0.00241	0.00403	CcSEcCtD
Secobarbital—Body temperature increased—Carbachol—glaucoma	0.00237	0.00397	CcSEcCtD
Secobarbital—Feeling abnormal—Methazolamide—glaucoma	0.00233	0.00391	CcSEcCtD
Secobarbital—Hypersensitivity—Carteolol—glaucoma	0.00231	0.00386	CcSEcCtD
Secobarbital—Ataxia—Betaxolol—glaucoma	0.00226	0.00378	CcSEcCtD
Secobarbital—Body temperature increased—Methazolamide—glaucoma	0.00224	0.00375	CcSEcCtD
Secobarbital—Dizziness—Metipranolol—glaucoma	0.00223	0.00374	CcSEcCtD
Secobarbital—Anxiety—Bimatoprost—glaucoma	0.00221	0.0037	CcSEcCtD
Secobarbital—Agitation—Acetazolamide—glaucoma	0.00221	0.00369	CcSEcCtD
Secobarbital—Hypersensitivity—Levobunolol—glaucoma	0.00218	0.00365	CcSEcCtD
Secobarbital—Tension—Dorzolamide—glaucoma	0.00216	0.00362	CcSEcCtD
Secobarbital—Nervousness—Dorzolamide—glaucoma	0.00214	0.00358	CcSEcCtD
Secobarbital—Rash—Metipranolol—glaucoma	0.00213	0.00356	CcSEcCtD
Secobarbital—Dermatitis—Metipranolol—glaucoma	0.00213	0.00356	CcSEcCtD
Secobarbital—Tension—Brinzolamide—glaucoma	0.00212	0.00356	CcSEcCtD
Secobarbital—Headache—Metipranolol—glaucoma	0.00212	0.00354	CcSEcCtD
Secobarbital—Nervousness—Brinzolamide—glaucoma	0.0021	0.00352	CcSEcCtD
Secobarbital—Dermatitis exfoliative—Timolol—glaucoma	0.00208	0.00348	CcSEcCtD
Secobarbital—Dizziness—Carteolol—glaucoma	0.00207	0.00346	CcSEcCtD
Secobarbital—Syncope—Brimonidine—glaucoma	0.00207	0.00346	CcSEcCtD
Secobarbital—Tension—Pilocarpine—glaucoma	0.00204	0.00342	CcSEcCtD
Secobarbital—Dizziness—Diclofenamide—glaucoma	0.00203	0.0034	CcSEcCtD
Secobarbital—Loss of consciousness—Brimonidine—glaucoma	0.00203	0.00339	CcSEcCtD
Secobarbital—Nervousness—Pilocarpine—glaucoma	0.00202	0.00338	CcSEcCtD
Secobarbital—Angioedema—Dorzolamide—glaucoma	0.00201	0.00337	CcSEcCtD
Secobarbital—Nausea—Metipranolol—glaucoma	0.00201	0.00336	CcSEcCtD
Secobarbital—Agitation—Brinzolamide—glaucoma	0.00199	0.00333	CcSEcCtD
Secobarbital—Dizziness—Carbachol—glaucoma	0.00199	0.00332	CcSEcCtD
Secobarbital—Confusional state—Acetazolamide—glaucoma	0.00198	0.00331	CcSEcCtD
Secobarbital—Syncope—Dorzolamide—glaucoma	0.00198	0.0033	CcSEcCtD
Secobarbital—Headache—Carteolol—glaucoma	0.00196	0.00328	CcSEcCtD
Secobarbital—Anxiety—Brimonidine—glaucoma	0.00196	0.00327	CcSEcCtD
Secobarbital—Vomiting—Diclofenamide—glaucoma	0.00196	0.00327	CcSEcCtD
Secobarbital—Dizziness—Levobunolol—glaucoma	0.00196	0.00327	CcSEcCtD
Secobarbital—Somnolence—Apraclonidine—glaucoma	0.00195	0.00326	CcSEcCtD
Secobarbital—Bradycardia—Clonidine—glaucoma	0.00194	0.00325	CcSEcCtD
Secobarbital—Rash—Diclofenamide—glaucoma	0.00194	0.00325	CcSEcCtD
Secobarbital—Loss of consciousness—Dorzolamide—glaucoma	0.00194	0.00324	CcSEcCtD
Secobarbital—Shock—Acetazolamide—glaucoma	0.00193	0.00323	CcSEcCtD
Secobarbital—Headache—Diclofenamide—glaucoma	0.00193	0.00322	CcSEcCtD
Secobarbital—Agitation—Pilocarpine—glaucoma	0.00191	0.0032	CcSEcCtD
Secobarbital—Vomiting—Carbachol—glaucoma	0.00191	0.00319	CcSEcCtD
Secobarbital—Hallucination—Clonidine—glaucoma	0.0019	0.00318	CcSEcCtD
Secobarbital—Rash—Carbachol—glaucoma	0.00189	0.00317	CcSEcCtD
Secobarbital—Dermatitis—Carbachol—glaucoma	0.00189	0.00317	CcSEcCtD
Secobarbital—Somnolence—Bimatoprost—glaucoma	0.00189	0.00316	CcSEcCtD
Secobarbital—Headache—Carbachol—glaucoma	0.00188	0.00315	CcSEcCtD
Secobarbital—Constipation—Apraclonidine—glaucoma	0.00187	0.00314	CcSEcCtD
Secobarbital—Anxiety—Dorzolamide—glaucoma	0.00187	0.00313	CcSEcCtD
Secobarbital—Syncope—Pilocarpine—glaucoma	0.00187	0.00312	CcSEcCtD
Secobarbital—Anxiety—Travoprost—glaucoma	0.00186	0.00311	CcSEcCtD
Secobarbital—Nausea—Carteolol—glaucoma	0.00186	0.00311	CcSEcCtD
Secobarbital—Headache—Levobunolol—glaucoma	0.00185	0.0031	CcSEcCtD
Secobarbital—Shock—Brimonidine—glaucoma	0.00185	0.0031	CcSEcCtD
Secobarbital—Loss of consciousness—Pilocarpine—glaucoma	0.00183	0.00306	CcSEcCtD
Secobarbital—Nausea—Diclofenamide—glaucoma	0.00183	0.00306	CcSEcCtD
Secobarbital—Dizziness—Latanoprost—glaucoma	0.00181	0.00303	CcSEcCtD
Secobarbital—Confusional state—Dorzolamide—glaucoma	0.00181	0.00303	CcSEcCtD
Secobarbital—Feeling abnormal—Apraclonidine—glaucoma	0.00181	0.00302	CcSEcCtD
Secobarbital—Vomiting—Methazolamide—glaucoma	0.0018	0.00301	CcSEcCtD
Secobarbital—Rash—Methazolamide—glaucoma	0.00179	0.00299	CcSEcCtD
Secobarbital—Dermatitis—Methazolamide—glaucoma	0.00178	0.00299	CcSEcCtD
Secobarbital—Nausea—Carbachol—glaucoma	0.00178	0.00298	CcSEcCtD
Secobarbital—Headache—Methazolamide—glaucoma	0.00177	0.00297	CcSEcCtD
Secobarbital—Shock—Dorzolamide—glaucoma	0.00177	0.00296	CcSEcCtD
Secobarbital—Anxiety—Pilocarpine—glaucoma	0.00177	0.00295	CcSEcCtD
Secobarbital—Hypotension—Brimonidine—glaucoma	0.00176	0.00294	CcSEcCtD
Secobarbital—Nausea—Levobunolol—glaucoma	0.00176	0.00294	CcSEcCtD
Secobarbital—Somnolence—Acetazolamide—glaucoma	0.00174	0.00292	CcSEcCtD
Secobarbital—Rash—Latanoprost—glaucoma	0.00173	0.00289	CcSEcCtD
Secobarbital—Dermatitis—Latanoprost—glaucoma	0.00173	0.00289	CcSEcCtD
Secobarbital—Headache—Latanoprost—glaucoma	0.00172	0.00287	CcSEcCtD
Secobarbital—Confusional state—Pilocarpine—glaucoma	0.00171	0.00287	CcSEcCtD
Secobarbital—Bradycardia—Betaxolol—glaucoma	0.00169	0.00283	CcSEcCtD
Secobarbital—Nausea—Methazolamide—glaucoma	0.00168	0.00282	CcSEcCtD
Secobarbital—Hypotension—Dorzolamide—glaucoma	0.00168	0.00281	CcSEcCtD
Secobarbital—Somnolence—Brimonidine—glaucoma	0.00167	0.0028	CcSEcCtD
Secobarbital—Hypotension—Travoprost—glaucoma	0.00167	0.0028	CcSEcCtD
Secobarbital—Shock—Pilocarpine—glaucoma	0.00167	0.0028	CcSEcCtD
Secobarbital—Hallucination—Betaxolol—glaucoma	0.00165	0.00277	CcSEcCtD
Secobarbital—Hypotension—Brinzolamide—glaucoma	0.00165	0.00276	CcSEcCtD
Secobarbital—Tension—Clonidine—glaucoma	0.00163	0.00273	CcSEcCtD
Secobarbital—Feeling abnormal—Acetazolamide—glaucoma	0.00162	0.0027	CcSEcCtD
Secobarbital—Hypersensitivity—Apraclonidine—glaucoma	0.00162	0.0027	CcSEcCtD
Secobarbital—Nervousness—Clonidine—glaucoma	0.00161	0.0027	CcSEcCtD
Secobarbital—Somnolence—Dorzolamide—glaucoma	0.0016	0.00267	CcSEcCtD
Secobarbital—Hypotension—Pilocarpine—glaucoma	0.00159	0.00266	CcSEcCtD
Secobarbital—Somnolence—Brinzolamide—glaucoma	0.00157	0.00263	CcSEcCtD
Secobarbital—Body temperature increased—Acetazolamide—glaucoma	0.00155	0.00259	CcSEcCtD
Secobarbital—Constipation—Travoprost—glaucoma	0.00153	0.00256	CcSEcCtD
Secobarbital—Agitation—Clonidine—glaucoma	0.00153	0.00256	CcSEcCtD
Secobarbital—Angioedema—Clonidine—glaucoma	0.00152	0.00254	CcSEcCtD
Secobarbital—Somnolence—Pilocarpine—glaucoma	0.00151	0.00253	CcSEcCtD
Secobarbital—Syncope—Clonidine—glaucoma	0.00149	0.00249	CcSEcCtD
Secobarbital—Feeling abnormal—Dorzolamide—glaucoma	0.00148	0.00248	CcSEcCtD
Secobarbital—Feeling abnormal—Travoprost—glaucoma	0.00147	0.00247	CcSEcCtD
Secobarbital—Loss of consciousness—Clonidine—glaucoma	0.00146	0.00244	CcSEcCtD
Secobarbital—Feeling abnormal—Brinzolamide—glaucoma	0.00146	0.00244	CcSEcCtD
Secobarbital—Constipation—Pilocarpine—glaucoma	0.00145	0.00243	CcSEcCtD
Secobarbital—Dizziness—Apraclonidine—glaucoma	0.00145	0.00243	CcSEcCtD
Secobarbital—Body temperature increased—Dorzolamide—glaucoma	0.00142	0.00238	CcSEcCtD
Secobarbital—Tension—Betaxolol—glaucoma	0.00142	0.00238	CcSEcCtD
Secobarbital—Anxiety—Clonidine—glaucoma	0.00141	0.00236	CcSEcCtD
Secobarbital—Dizziness—Bimatoprost—glaucoma	0.00141	0.00235	CcSEcCtD
Secobarbital—Nervousness—Betaxolol—glaucoma	0.00141	0.00235	CcSEcCtD
Secobarbital—Feeling abnormal—Pilocarpine—glaucoma	0.0014	0.00234	CcSEcCtD
Secobarbital—Vomiting—Apraclonidine—glaucoma	0.00139	0.00233	CcSEcCtD
Secobarbital—Hypersensitivity—Brimonidine—glaucoma	0.00139	0.00232	CcSEcCtD
Secobarbital—Bradycardia—Timolol—glaucoma	0.00138	0.00231	CcSEcCtD
Secobarbital—Dermatitis—Apraclonidine—glaucoma	0.00138	0.00231	CcSEcCtD
Secobarbital—Headache—Apraclonidine—glaucoma	0.00137	0.0023	CcSEcCtD
Secobarbital—Confusional state—Clonidine—glaucoma	0.00137	0.00229	CcSEcCtD
Secobarbital—Hallucination—Timolol—glaucoma	0.00135	0.00226	CcSEcCtD
Secobarbital—Body temperature increased—Pilocarpine—glaucoma	0.00134	0.00225	CcSEcCtD
Secobarbital—Rash—Bimatoprost—glaucoma	0.00134	0.00224	CcSEcCtD
Secobarbital—Dermatitis—Bimatoprost—glaucoma	0.00134	0.00224	CcSEcCtD
Secobarbital—Shock—Clonidine—glaucoma	0.00133	0.00223	CcSEcCtD
Secobarbital—Headache—Bimatoprost—glaucoma	0.00133	0.00223	CcSEcCtD
Secobarbital—Hypersensitivity—Dorzolamide—glaucoma	0.00132	0.00222	CcSEcCtD
Secobarbital—Hypersensitivity—Travoprost—glaucoma	0.00132	0.00221	CcSEcCtD
Secobarbital—Nausea—Apraclonidine—glaucoma	0.0013	0.00218	CcSEcCtD
Secobarbital—Hypersensitivity—Brinzolamide—glaucoma	0.0013	0.00218	CcSEcCtD
Secobarbital—Syncope—Betaxolol—glaucoma	0.0013	0.00217	CcSEcCtD
Secobarbital—Dizziness—Acetazolamide—glaucoma	0.0013	0.00217	CcSEcCtD
Secobarbital—Loss of consciousness—Betaxolol—glaucoma	0.00127	0.00213	CcSEcCtD
Secobarbital—Hypotension—Clonidine—glaucoma	0.00127	0.00212	CcSEcCtD
Secobarbital—Nausea—Bimatoprost—glaucoma	0.00126	0.00211	CcSEcCtD
Secobarbital—Hypersensitivity—Pilocarpine—glaucoma	0.00125	0.00209	CcSEcCtD
Secobarbital—Vomiting—Acetazolamide—glaucoma	0.00125	0.00209	CcSEcCtD
Secobarbital—Dizziness—Brimonidine—glaucoma	0.00124	0.00208	CcSEcCtD
Secobarbital—Headache—Acetazolamide—glaucoma	0.00123	0.00206	CcSEcCtD
Secobarbital—Anxiety—Betaxolol—glaucoma	0.00123	0.00205	CcSEcCtD
Secobarbital—Somnolence—Clonidine—glaucoma	0.00121	0.00202	CcSEcCtD
Secobarbital—Confusional state—Betaxolol—glaucoma	0.00119	0.00199	CcSEcCtD
Secobarbital—Dizziness—Dorzolamide—glaucoma	0.00119	0.00199	CcSEcCtD
Secobarbital—Rash—Brimonidine—glaucoma	0.00119	0.00199	CcSEcCtD
Secobarbital—Dermatitis—Brimonidine—glaucoma	0.00119	0.00198	CcSEcCtD
Secobarbital—Dizziness—Travoprost—glaucoma	0.00118	0.00198	CcSEcCtD
Secobarbital—Headache—Brimonidine—glaucoma	0.00118	0.00197	CcSEcCtD
Secobarbital—CHRNA7—SIDS Susceptibility Pathways—LMX1B—glaucoma	0.00118	0.031	CbGpPWpGaD
Secobarbital—Dizziness—Brinzolamide—glaucoma	0.00117	0.00196	CcSEcCtD
Secobarbital—Nausea—Acetazolamide—glaucoma	0.00116	0.00195	CcSEcCtD
Secobarbital—Shock—Betaxolol—glaucoma	0.00116	0.00194	CcSEcCtD
Secobarbital—Tension—Timolol—glaucoma	0.00116	0.00194	CcSEcCtD
Secobarbital—Constipation—Clonidine—glaucoma	0.00116	0.00194	CcSEcCtD
Secobarbital—Nervousness—Timolol—glaucoma	0.00115	0.00192	CcSEcCtD
Secobarbital—Vomiting—Dorzolamide—glaucoma	0.00114	0.00191	CcSEcCtD
Secobarbital—Rash—Dorzolamide—glaucoma	0.00113	0.0019	CcSEcCtD
Secobarbital—Dermatitis—Dorzolamide—glaucoma	0.00113	0.00189	CcSEcCtD
Secobarbital—Rash—Travoprost—glaucoma	0.00113	0.00189	CcSEcCtD
Secobarbital—Dermatitis—Travoprost—glaucoma	0.00113	0.00189	CcSEcCtD
Secobarbital—Headache—Dorzolamide—glaucoma	0.00113	0.00188	CcSEcCtD
Secobarbital—Vomiting—Brinzolamide—glaucoma	0.00112	0.00188	CcSEcCtD
Secobarbital—Dizziness—Pilocarpine—glaucoma	0.00112	0.00188	CcSEcCtD
Secobarbital—Headache—Travoprost—glaucoma	0.00112	0.00188	CcSEcCtD
Secobarbital—Nausea—Brimonidine—glaucoma	0.00112	0.00187	CcSEcCtD
Secobarbital—Feeling abnormal—Clonidine—glaucoma	0.00112	0.00187	CcSEcCtD
Secobarbital—Rash—Brinzolamide—glaucoma	0.00111	0.00186	CcSEcCtD
Secobarbital—Dermatitis—Brinzolamide—glaucoma	0.00111	0.00186	CcSEcCtD
Secobarbital—Headache—Brinzolamide—glaucoma	0.00111	0.00185	CcSEcCtD
Secobarbital—Hypotension—Betaxolol—glaucoma	0.0011	0.00185	CcSEcCtD
Secobarbital—Angioedema—Timolol—glaucoma	0.00108	0.00181	CcSEcCtD
Secobarbital—Vomiting—Pilocarpine—glaucoma	0.00108	0.00181	CcSEcCtD
Secobarbital—Body temperature increased—Clonidine—glaucoma	0.00107	0.00179	CcSEcCtD
Secobarbital—Rash—Pilocarpine—glaucoma	0.00107	0.00179	CcSEcCtD
Secobarbital—Dermatitis—Pilocarpine—glaucoma	0.00107	0.00179	CcSEcCtD
Secobarbital—Nausea—Dorzolamide—glaucoma	0.00107	0.00179	CcSEcCtD
Secobarbital—Headache—Pilocarpine—glaucoma	0.00106	0.00178	CcSEcCtD
Secobarbital—Nausea—Travoprost—glaucoma	0.00106	0.00178	CcSEcCtD
Secobarbital—Syncope—Timolol—glaucoma	0.00106	0.00177	CcSEcCtD
Secobarbital—Nausea—Brinzolamide—glaucoma	0.00105	0.00176	CcSEcCtD
Secobarbital—Loss of consciousness—Timolol—glaucoma	0.00104	0.00174	CcSEcCtD
Secobarbital—Constipation—Betaxolol—glaucoma	0.00101	0.00169	CcSEcCtD
Secobarbital—Nausea—Pilocarpine—glaucoma	0.00101	0.00169	CcSEcCtD
Secobarbital—Anxiety—Timolol—glaucoma	0.001	0.00168	CcSEcCtD
Secobarbital—Hypersensitivity—Clonidine—glaucoma	0.000999	0.00167	CcSEcCtD
Secobarbital—Feeling abnormal—Betaxolol—glaucoma	0.000973	0.00163	CcSEcCtD
Secobarbital—Confusional state—Timolol—glaucoma	0.000973	0.00163	CcSEcCtD
Secobarbital—CHRNA4—SIDS Susceptibility Pathways—LMX1B—glaucoma	0.000958	0.0253	CbGpPWpGaD
Secobarbital—Shock—Timolol—glaucoma	0.000949	0.00159	CcSEcCtD
Secobarbital—Body temperature increased—Betaxolol—glaucoma	0.000933	0.00156	CcSEcCtD
Secobarbital—Hypotension—Timolol—glaucoma	0.000901	0.00151	CcSEcCtD
Secobarbital—Dizziness—Clonidine—glaucoma	0.000897	0.0015	CcSEcCtD
Secobarbital—Hypersensitivity—Betaxolol—glaucoma	0.00087	0.00146	CcSEcCtD
Secobarbital—Vomiting—Clonidine—glaucoma	0.000862	0.00144	CcSEcCtD
Secobarbital—Somnolence—Timolol—glaucoma	0.000858	0.00143	CcSEcCtD
Secobarbital—Rash—Clonidine—glaucoma	0.000855	0.00143	CcSEcCtD
Secobarbital—Dermatitis—Clonidine—glaucoma	0.000854	0.00143	CcSEcCtD
Secobarbital—CYP1A2—Sulindac Metabolic Pathway—CYP1B1—glaucoma	0.000852	0.0225	CbGpPWpGaD
Secobarbital—Headache—Clonidine—glaucoma	0.00085	0.00142	CcSEcCtD
Secobarbital—CYP2C8—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1B1—glaucoma	0.000841	0.0222	CbGpPWpGaD
Secobarbital—Nausea—Clonidine—glaucoma	0.000806	0.00135	CcSEcCtD
Secobarbital—Feeling abnormal—Timolol—glaucoma	0.000795	0.00133	CcSEcCtD
Secobarbital—Dizziness—Betaxolol—glaucoma	0.000781	0.00131	CcSEcCtD
Secobarbital—CYP2C8—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1B1—glaucoma	0.000765	0.0202	CbGpPWpGaD
Secobarbital—Body temperature increased—Timolol—glaucoma	0.000763	0.00128	CcSEcCtD
Secobarbital—Vomiting—Betaxolol—glaucoma	0.000751	0.00126	CcSEcCtD
Secobarbital—Rash—Betaxolol—glaucoma	0.000745	0.00125	CcSEcCtD
Secobarbital—Dermatitis—Betaxolol—glaucoma	0.000744	0.00124	CcSEcCtD
Secobarbital—Headache—Betaxolol—glaucoma	0.00074	0.00124	CcSEcCtD
Secobarbital—Hypersensitivity—Timolol—glaucoma	0.000711	0.00119	CcSEcCtD
Secobarbital—Nausea—Betaxolol—glaucoma	0.000701	0.00117	CcSEcCtD
Secobarbital—CYP2C9—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1B1—glaucoma	0.000684	0.018	CbGpPWpGaD
Secobarbital—Dizziness—Timolol—glaucoma	0.000638	0.00107	CcSEcCtD
Secobarbital—CYP2C9—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1B1—glaucoma	0.000623	0.0164	CbGpPWpGaD
Secobarbital—Vomiting—Timolol—glaucoma	0.000613	0.00103	CcSEcCtD
Secobarbital—Rash—Timolol—glaucoma	0.000608	0.00102	CcSEcCtD
Secobarbital—Dermatitis—Timolol—glaucoma	0.000608	0.00102	CcSEcCtD
Secobarbital—Headache—Timolol—glaucoma	0.000604	0.00101	CcSEcCtD
Secobarbital—GABRA1—SIDS Susceptibility Pathways—LMX1B—glaucoma	0.000593	0.0156	CbGpPWpGaD
Secobarbital—CYP1A2—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1B1—glaucoma	0.000585	0.0154	CbGpPWpGaD
Secobarbital—Nausea—Timolol—glaucoma	0.000573	0.000959	CcSEcCtD
Secobarbital—CYP1A2—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1B1—glaucoma	0.000532	0.014	CbGpPWpGaD
Secobarbital—CYP1A2—Aflatoxin B1 metabolism—GSTM1—glaucoma	0.00052	0.0137	CbGpPWpGaD
Secobarbital—GRIK2—Transmission across Chemical Synapses—SLC6A13—glaucoma	0.000477	0.0126	CbGpPWpGaD
Secobarbital—GRIA2—BDNF signaling pathway—NCK2—glaucoma	0.000444	0.0117	CbGpPWpGaD
Secobarbital—CHRNA7—Transmission across Chemical Synapses—SLC6A13—glaucoma	0.000434	0.0114	CbGpPWpGaD
Secobarbital—CHRNA7—SIDS Susceptibility Pathways—HDAC9—glaucoma	0.000421	0.0111	CbGpPWpGaD
Secobarbital—CYP1A2—Estrogen Receptor Pathway—CYP1B1—glaucoma	0.000396	0.0105	CbGpPWpGaD
Secobarbital—CYP2C8—Tamoxifen metabolism—CYP1B1—glaucoma	0.000388	0.0102	CbGpPWpGaD
Secobarbital—GRIK2—Neuronal System—SLC6A13—glaucoma	0.000366	0.00964	CbGpPWpGaD
Secobarbital—GRIA2—Transmission across Chemical Synapses—SLC6A13—glaucoma	0.000365	0.00962	CbGpPWpGaD
Secobarbital—CHRNA4—Transmission across Chemical Synapses—SLC6A13—glaucoma	0.000354	0.00933	CbGpPWpGaD
Secobarbital—GRIK2—Transmission across Chemical Synapses—SLC6A1—glaucoma	0.000349	0.00921	CbGpPWpGaD
Secobarbital—CHRNA4—SIDS Susceptibility Pathways—HDAC9—glaucoma	0.000343	0.00906	CbGpPWpGaD
Secobarbital—CHRNA7—Neuronal System—SLC6A13—glaucoma	0.000333	0.00877	CbGpPWpGaD
Secobarbital—CHRNA7—Transmission across Chemical Synapses—SLC6A1—glaucoma	0.000318	0.00838	CbGpPWpGaD
Secobarbital—CYP2C9—Tamoxifen metabolism—CYP1B1—glaucoma	0.000316	0.00834	CbGpPWpGaD
Secobarbital—CYP1A2—Estrogen metabolism—CYP1B1—glaucoma	0.000306	0.00806	CbGpPWpGaD
Secobarbital—GABRA6—Transmission across Chemical Synapses—SLC6A13—glaucoma	0.000304	0.008	CbGpPWpGaD
Secobarbital—CHRNA7—SIDS Susceptibility Pathways—NTRK2—glaucoma	0.000302	0.00795	CbGpPWpGaD
Secobarbital—GABRA4—Transmission across Chemical Synapses—SLC6A13—glaucoma	0.0003	0.0079	CbGpPWpGaD
Secobarbital—GRIA2—Neuronal System—SLC6A13—glaucoma	0.00028	0.00737	CbGpPWpGaD
Secobarbital—GABRA6—Transmembrane transport of small molecules—PEX19—glaucoma	0.000277	0.00732	CbGpPWpGaD
Secobarbital—GABRB2—Transmission across Chemical Synapses—SLC6A13—glaucoma	0.000274	0.00723	CbGpPWpGaD
Secobarbital—GABRA4—Transmembrane transport of small molecules—PEX19—glaucoma	0.000274	0.00722	CbGpPWpGaD
Secobarbital—CHRNA4—Neuronal System—SLC6A13—glaucoma	0.000271	0.00715	CbGpPWpGaD
Secobarbital—GRIA2—BDNF signaling pathway—NTRK2—glaucoma	0.00027	0.00712	CbGpPWpGaD
Secobarbital—CYP1A2—Tamoxifen metabolism—CYP1B1—glaucoma	0.00027	0.00712	CbGpPWpGaD
Secobarbital—GRIK2—Neuronal System—SLC6A1—glaucoma	0.000268	0.00706	CbGpPWpGaD
Secobarbital—GRIA2—Transmission across Chemical Synapses—SLC6A1—glaucoma	0.000267	0.00704	CbGpPWpGaD
Secobarbital—GABRA5—Transmission across Chemical Synapses—SLC6A13—glaucoma	0.000266	0.00702	CbGpPWpGaD
Secobarbital—GABRA3—Transmission across Chemical Synapses—SLC6A13—glaucoma	0.000262	0.0069	CbGpPWpGaD
Secobarbital—CHRNA4—Transmission across Chemical Synapses—SLC6A1—glaucoma	0.000259	0.00683	CbGpPWpGaD
Secobarbital—GABRA2—Transmission across Chemical Synapses—SLC6A13—glaucoma	0.000257	0.00678	CbGpPWpGaD
Secobarbital—GABRG2—Transmission across Chemical Synapses—SLC6A13—glaucoma	0.000251	0.00661	CbGpPWpGaD
Secobarbital—GABRB2—Transmembrane transport of small molecules—PEX19—glaucoma	0.000251	0.00661	CbGpPWpGaD
Secobarbital—CHRNA4—SIDS Susceptibility Pathways—NTRK2—glaucoma	0.000246	0.00648	CbGpPWpGaD
Secobarbital—CYP1A2—Estrogen metabolism—GSTM1—glaucoma	0.000244	0.00644	CbGpPWpGaD
Secobarbital—CHRNA7—Neuronal System—SLC6A1—glaucoma	0.000244	0.00642	CbGpPWpGaD
Secobarbital—GABRA5—Transmembrane transport of small molecules—PEX19—glaucoma	0.000243	0.00642	CbGpPWpGaD
Secobarbital—GABRA3—Transmembrane transport of small molecules—PEX19—glaucoma	0.000239	0.0063	CbGpPWpGaD
Secobarbital—GABRA2—Transmembrane transport of small molecules—PEX19—glaucoma	0.000235	0.00619	CbGpPWpGaD
Secobarbital—GABRA6—Neuronal System—SLC6A13—glaucoma	0.000233	0.00613	CbGpPWpGaD
Secobarbital—GRIA2—BDNF signaling pathway—NGFR—glaucoma	0.000232	0.00611	CbGpPWpGaD
Secobarbital—GABRA4—Neuronal System—SLC6A13—glaucoma	0.00023	0.00606	CbGpPWpGaD
Secobarbital—GABRG2—Transmembrane transport of small molecules—PEX19—glaucoma	0.000229	0.00604	CbGpPWpGaD
Secobarbital—CHRNA7—SIDS Susceptibility Pathways—BDNF—glaucoma	0.000225	0.00593	CbGpPWpGaD
Secobarbital—GABRA6—Transmission across Chemical Synapses—SLC6A1—glaucoma	0.000222	0.00586	CbGpPWpGaD
Secobarbital—GRIA2—BDNF signaling pathway—NTRK1—glaucoma	0.00022	0.00581	CbGpPWpGaD
Secobarbital—GABRA4—Transmission across Chemical Synapses—SLC6A1—glaucoma	0.000219	0.00578	CbGpPWpGaD
Secobarbital—GABRA1—Transmission across Chemical Synapses—SLC6A13—glaucoma	0.000219	0.00578	CbGpPWpGaD
Secobarbital—CHRNA7—SIDS Susceptibility Pathways—IL1A—glaucoma	0.000216	0.0057	CbGpPWpGaD
Secobarbital—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	0.000215	0.00567	CbGpPWpGaD
Secobarbital—GABRA1—SIDS Susceptibility Pathways—HDAC9—glaucoma	0.000213	0.00561	CbGpPWpGaD
Secobarbital—GABRB2—Neuronal System—SLC6A13—glaucoma	0.00021	0.00554	CbGpPWpGaD
Secobarbital—CYP1A2—Melatonin metabolism and effects—CYP1B1—glaucoma	0.000209	0.0055	CbGpPWpGaD
Secobarbital—GRIA2—Neuronal System—SLC6A1—glaucoma	0.000205	0.0054	CbGpPWpGaD
Secobarbital—GABRA5—Neuronal System—SLC6A13—glaucoma	0.000204	0.00538	CbGpPWpGaD
Secobarbital—GRIA2—BDNF signaling pathway—BDNF—glaucoma	0.000202	0.00532	CbGpPWpGaD
Secobarbital—GABRB2—Transmission across Chemical Synapses—SLC6A1—glaucoma	0.000201	0.00529	CbGpPWpGaD
Secobarbital—GABRA3—Neuronal System—SLC6A13—glaucoma	0.0002	0.00528	CbGpPWpGaD
Secobarbital—GABRA1—Transmembrane transport of small molecules—PEX19—glaucoma	0.0002	0.00528	CbGpPWpGaD
Secobarbital—CHRNA7—SIDS Susceptibility Pathways—NGF—glaucoma	0.0002	0.00527	CbGpPWpGaD
Secobarbital—CHRNA7—SIDS Susceptibility Pathways—NR3C1—glaucoma	0.000199	0.00524	CbGpPWpGaD
Secobarbital—CHRNA4—Neuronal System—SLC6A1—glaucoma	0.000199	0.00523	CbGpPWpGaD
Secobarbital—GABRA2—Neuronal System—SLC6A13—glaucoma	0.000197	0.00519	CbGpPWpGaD
Secobarbital—GABRA5—Transmission across Chemical Synapses—SLC6A1—glaucoma	0.000195	0.00514	CbGpPWpGaD
Secobarbital—CYP2C8—Arachidonic acid metabolism—CYP1B1—glaucoma	0.000194	0.00512	CbGpPWpGaD
Secobarbital—GABRG2—Neuronal System—SLC6A13—glaucoma	0.000192	0.00507	CbGpPWpGaD
Secobarbital—GABRA3—Transmission across Chemical Synapses—SLC6A1—glaucoma	0.000191	0.00505	CbGpPWpGaD
Secobarbital—GABRA2—Transmission across Chemical Synapses—SLC6A1—glaucoma	0.000188	0.00496	CbGpPWpGaD
Secobarbital—GABRA6—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.000187	0.00494	CbGpPWpGaD
Secobarbital—GABRA4—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.000185	0.00488	CbGpPWpGaD
Secobarbital—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	0.000184	0.00484	CbGpPWpGaD
Secobarbital—GABRG2—Transmission across Chemical Synapses—SLC6A1—glaucoma	0.000184	0.00484	CbGpPWpGaD
Secobarbital—CHRNA4—SIDS Susceptibility Pathways—BDNF—glaucoma	0.000183	0.00484	CbGpPWpGaD
Secobarbital—GRIA2—BDNF signaling pathway—NGF—glaucoma	0.000179	0.00472	CbGpPWpGaD
Secobarbital—CHRNA4—SIDS Susceptibility Pathways—IL1A—glaucoma	0.000176	0.00464	CbGpPWpGaD
Secobarbital—GABRA6—Neuronal System—SLC6A1—glaucoma	0.00017	0.00449	CbGpPWpGaD
Secobarbital—GABRB2—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.000169	0.00446	CbGpPWpGaD
Secobarbital—CYP1A2—Melatonin metabolism and effects—EDN1—glaucoma	0.000169	0.00445	CbGpPWpGaD
Secobarbital—GABRA4—Neuronal System—SLC6A1—glaucoma	0.000168	0.00443	CbGpPWpGaD
Secobarbital—GABRA1—Neuronal System—SLC6A13—glaucoma	0.000168	0.00443	CbGpPWpGaD
Secobarbital—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.000168	0.00442	CbGpPWpGaD
Secobarbital—CYP2C8—Oxidation by Cytochrome P450—CYP1B1—glaucoma	0.000166	0.00436	CbGpPWpGaD
Secobarbital—GABRA5—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.000164	0.00434	CbGpPWpGaD
Secobarbital—CHRNA4—SIDS Susceptibility Pathways—NGF—glaucoma	0.000163	0.00429	CbGpPWpGaD
Secobarbital—CHRNA4—SIDS Susceptibility Pathways—NR3C1—glaucoma	0.000162	0.00427	CbGpPWpGaD
Secobarbital—GABRA3—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.000161	0.00426	CbGpPWpGaD
Secobarbital—GABRA1—Transmission across Chemical Synapses—SLC6A1—glaucoma	0.00016	0.00423	CbGpPWpGaD
Secobarbital—GABRA2—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.000159	0.00418	CbGpPWpGaD
Secobarbital—CYP2C9—Arachidonic acid metabolism—CYP1B1—glaucoma	0.000158	0.00416	CbGpPWpGaD
Secobarbital—GABRG2—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.000155	0.00408	CbGpPWpGaD
Secobarbital—GABRB2—Neuronal System—SLC6A1—glaucoma	0.000154	0.00405	CbGpPWpGaD
Secobarbital—GABRA1—SIDS Susceptibility Pathways—NTRK2—glaucoma	0.000152	0.00401	CbGpPWpGaD
Secobarbital—GABRA5—Neuronal System—SLC6A1—glaucoma	0.000149	0.00394	CbGpPWpGaD
Secobarbital—GRIA2—BDNF signaling pathway—BAD—glaucoma	0.000148	0.00389	CbGpPWpGaD
Secobarbital—GABRA3—Neuronal System—SLC6A1—glaucoma	0.000147	0.00387	CbGpPWpGaD
Secobarbital—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1B1—glaucoma	0.000144	0.0038	CbGpPWpGaD
Secobarbital—CYP1A2—Aryl Hydrocarbon Receptor—CYP1B1—glaucoma	0.000144	0.0038	CbGpPWpGaD
Secobarbital—CYP1A2—Tryptophan metabolism—CYP1B1—glaucoma	0.000144	0.0038	CbGpPWpGaD
Secobarbital—GABRA2—Neuronal System—SLC6A1—glaucoma	0.000144	0.0038	CbGpPWpGaD
Secobarbital—GABRG2—Neuronal System—SLC6A1—glaucoma	0.000141	0.00371	CbGpPWpGaD
Secobarbital—CYP1A2—Melatonin metabolism and effects—APOE—glaucoma	0.000137	0.00362	CbGpPWpGaD
Secobarbital—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.000136	0.0036	CbGpPWpGaD
Secobarbital—CYP2C8—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.000136	0.00358	CbGpPWpGaD
Secobarbital—GABRA1—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.000135	0.00357	CbGpPWpGaD
Secobarbital—CYP1A2—Arachidonic acid metabolism—CYP1B1—glaucoma	0.000135	0.00356	CbGpPWpGaD
Secobarbital—CYP2C9—Oxidation by Cytochrome P450—CYP1B1—glaucoma	0.000135	0.00355	CbGpPWpGaD
Secobarbital—GABRA6—Transmembrane transport of small molecules—SLC6A13—glaucoma	0.000125	0.0033	CbGpPWpGaD
Secobarbital—GABRA4—Transmembrane transport of small molecules—SLC6A13—glaucoma	0.000123	0.00326	CbGpPWpGaD
Secobarbital—GABRA1—Neuronal System—SLC6A1—glaucoma	0.000123	0.00324	CbGpPWpGaD
Secobarbital—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.000117	0.00308	CbGpPWpGaD
Secobarbital—CYP1A2—Oxidation by Cytochrome P450—CYP1B1—glaucoma	0.000115	0.00304	CbGpPWpGaD
Secobarbital—GABRA1—SIDS Susceptibility Pathways—BDNF—glaucoma	0.000114	0.00299	CbGpPWpGaD
Secobarbital—GABRB2—Transmembrane transport of small molecules—SLC6A13—glaucoma	0.000113	0.00298	CbGpPWpGaD
Secobarbital—CYP2C9—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.000111	0.00292	CbGpPWpGaD
Secobarbital—GABRA5—Transmembrane transport of small molecules—SLC6A13—glaucoma	0.00011	0.00289	CbGpPWpGaD
Secobarbital—GABRA1—SIDS Susceptibility Pathways—IL1A—glaucoma	0.000109	0.00288	CbGpPWpGaD
Secobarbital—CYP1A2—Phase II conjugation—GSTT1—glaucoma	0.000108	0.00284	CbGpPWpGaD
Secobarbital—GABRA3—Transmembrane transport of small molecules—SLC6A13—glaucoma	0.000108	0.00284	CbGpPWpGaD
Secobarbital—GABRA2—Transmembrane transport of small molecules—SLC6A13—glaucoma	0.000106	0.00279	CbGpPWpGaD
Secobarbital—GABRG2—Transmembrane transport of small molecules—SLC6A13—glaucoma	0.000103	0.00272	CbGpPWpGaD
Secobarbital—GABRA1—SIDS Susceptibility Pathways—NGF—glaucoma	0.000101	0.00266	CbGpPWpGaD
Secobarbital—GABRA1—SIDS Susceptibility Pathways—NR3C1—glaucoma	0.0001	0.00265	CbGpPWpGaD
Secobarbital—CHRNA7—SIDS Susceptibility Pathways—VEGFA—glaucoma	9.54e-05	0.00252	CbGpPWpGaD
Secobarbital—CYP1A2—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	9.46e-05	0.00249	CbGpPWpGaD
Secobarbital—GABRA6—Transmembrane transport of small molecules—SLC6A1—glaucoma	9.15e-05	0.00241	CbGpPWpGaD
Secobarbital—CYP2C8—Biological oxidations—GSTT1—glaucoma	9.06e-05	0.00239	CbGpPWpGaD
Secobarbital—GABRA4—Transmembrane transport of small molecules—SLC6A1—glaucoma	9.04e-05	0.00238	CbGpPWpGaD
Secobarbital—GABRA1—Transmembrane transport of small molecules—SLC6A13—glaucoma	9.03e-05	0.00238	CbGpPWpGaD
Secobarbital—CYP2C8—Arachidonic acid metabolism—PTGS2—glaucoma	8.75e-05	0.00231	CbGpPWpGaD
Secobarbital—GABRB2—Transmembrane transport of small molecules—SLC6A1—glaucoma	8.27e-05	0.00218	CbGpPWpGaD
Secobarbital—CHRNA7—SIDS Susceptibility Pathways—TNF—glaucoma	8.18e-05	0.00216	CbGpPWpGaD
Secobarbital—GABRA5—Transmembrane transport of small molecules—SLC6A1—glaucoma	8.03e-05	0.00212	CbGpPWpGaD
Secobarbital—GABRA3—Transmembrane transport of small molecules—SLC6A1—glaucoma	7.89e-05	0.00208	CbGpPWpGaD
Secobarbital—CHRNA4—SIDS Susceptibility Pathways—VEGFA—glaucoma	7.78e-05	0.00205	CbGpPWpGaD
Secobarbital—GABRA2—Transmembrane transport of small molecules—SLC6A1—glaucoma	7.75e-05	0.00204	CbGpPWpGaD
Secobarbital—GABRG2—Transmembrane transport of small molecules—SLC6A1—glaucoma	7.56e-05	0.00199	CbGpPWpGaD
Secobarbital—CYP2C9—Biological oxidations—GSTT1—glaucoma	7.38e-05	0.00195	CbGpPWpGaD
Secobarbital—CYP2C8—Biological oxidations—CYP1B1—glaucoma	7.22e-05	0.0019	CbGpPWpGaD
Secobarbital—CYP2C8—Metapathway biotransformation—CYP1B1—glaucoma	7.12e-05	0.00188	CbGpPWpGaD
Secobarbital—CYP2C9—Arachidonic acid metabolism—PTGS2—glaucoma	7.12e-05	0.00188	CbGpPWpGaD
Secobarbital—CYP1A2—Phase II conjugation—GSTM1—glaucoma	6.86e-05	0.00181	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism of lipids and lipoproteins—CTSA—glaucoma	6.75e-05	0.00178	CbGpPWpGaD
Secobarbital—CHRNA4—SIDS Susceptibility Pathways—TNF—glaucoma	6.67e-05	0.00176	CbGpPWpGaD
Secobarbital—GABRA1—Transmembrane transport of small molecules—SLC6A1—glaucoma	6.61e-05	0.00174	CbGpPWpGaD
Secobarbital—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—glaucoma	6.5e-05	0.00171	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—CA5A—glaucoma	6.35e-05	0.00167	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—NARFL—glaucoma	6.35e-05	0.00167	CbGpPWpGaD
Secobarbital—CYP1A2—Biological oxidations—GSTT1—glaucoma	6.3e-05	0.00166	CbGpPWpGaD
Secobarbital—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—glaucoma	6.16e-05	0.00162	CbGpPWpGaD
Secobarbital—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—glaucoma	6.16e-05	0.00162	CbGpPWpGaD
Secobarbital—CYP1A2—Arachidonic acid metabolism—PTGS2—glaucoma	6.08e-05	0.0016	CbGpPWpGaD
Secobarbital—CYP2C9—Biological oxidations—CYP1B1—glaucoma	5.88e-05	0.00155	CbGpPWpGaD
Secobarbital—CYP2C9—Metapathway biotransformation—CYP1B1—glaucoma	5.8e-05	0.00153	CbGpPWpGaD
Secobarbital—CYP2C8—Biological oxidations—GSTM1—glaucoma	5.77e-05	0.00152	CbGpPWpGaD
Secobarbital—CYP2C8—Metapathway biotransformation—GSTM1—glaucoma	5.69e-05	0.0015	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism of lipids and lipoproteins—CTSA—glaucoma	5.49e-05	0.00145	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—NARFL—glaucoma	5.17e-05	0.00136	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—CA5A—glaucoma	5.17e-05	0.00136	CbGpPWpGaD
Secobarbital—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—glaucoma	5.12e-05	0.00135	CbGpPWpGaD
Secobarbital—CYP1A2—Biological oxidations—CYP1B1—glaucoma	5.02e-05	0.00132	CbGpPWpGaD
Secobarbital—CYP1A2—Metapathway biotransformation—CYP1B1—glaucoma	4.95e-05	0.00131	CbGpPWpGaD
Secobarbital—GABRA1—SIDS Susceptibility Pathways—VEGFA—glaucoma	4.82e-05	0.00127	CbGpPWpGaD
Secobarbital—CYP2C9—Biological oxidations—GSTM1—glaucoma	4.7e-05	0.00124	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism of lipids and lipoproteins—CTSA—glaucoma	4.69e-05	0.00124	CbGpPWpGaD
Secobarbital—CYP2C9—Metapathway biotransformation—GSTM1—glaucoma	4.63e-05	0.00122	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—CA5A—glaucoma	4.42e-05	0.00116	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—NARFL—glaucoma	4.42e-05	0.00116	CbGpPWpGaD
Secobarbital—CYP1A2—Aryl Hydrocarbon Receptor—TNF—glaucoma	4.39e-05	0.00116	CbGpPWpGaD
Secobarbital—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—glaucoma	4.39e-05	0.00116	CbGpPWpGaD
Secobarbital—GABRA1—SIDS Susceptibility Pathways—TNF—glaucoma	4.13e-05	0.00109	CbGpPWpGaD
Secobarbital—CYP1A2—Biological oxidations—GSTM1—glaucoma	4.02e-05	0.00106	CbGpPWpGaD
Secobarbital—CYP1A2—Metapathway biotransformation—GSTM1—glaucoma	3.96e-05	0.00104	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—CA1—glaucoma	3.1e-05	0.000818	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—CTSA—glaucoma	3e-05	0.000792	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—CA2—glaucoma	2.84e-05	0.000748	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	2.77e-05	0.000731	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	2.77e-05	0.000731	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—CA1—glaucoma	2.53e-05	0.000666	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—CTSA—glaucoma	2.45e-05	0.000645	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—CA2—glaucoma	2.31e-05	0.000609	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	2.26e-05	0.000595	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	2.26e-05	0.000595	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—CA1—glaucoma	2.16e-05	0.000569	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—CTSA—glaucoma	2.09e-05	0.000551	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—TXN—glaucoma	2e-05	0.000527	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—CA2—glaucoma	1.97e-05	0.00052	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	1.93e-05	0.000509	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	1.93e-05	0.000509	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism of lipids and lipoproteins—APOE—glaucoma	1.82e-05	0.000481	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—glaucoma	1.81e-05	0.000477	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—TXN—glaucoma	1.63e-05	0.000429	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—GSTT1—glaucoma	1.55e-05	0.000409	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism of lipids and lipoproteins—APOE—glaucoma	1.48e-05	0.000391	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—glaucoma	1.47e-05	0.000388	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—TXN—glaucoma	1.39e-05	0.000367	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism of lipids and lipoproteins—APOE—glaucoma	1.27e-05	0.000335	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—GSTT1—glaucoma	1.26e-05	0.000333	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—glaucoma	1.26e-05	0.000331	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	1.25e-05	0.00033	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—ABCA1—glaucoma	1.24e-05	0.000326	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—CYP1B1—glaucoma	1.24e-05	0.000326	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—GSTT1—glaucoma	1.08e-05	0.000284	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	1.02e-05	0.000268	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—ABCA1—glaucoma	1.01e-05	0.000265	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—CYP1B1—glaucoma	1.01e-05	0.000265	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—GSTM1—glaucoma	9.87e-06	0.00026	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—MTHFR—glaucoma	8.73e-06	0.00023	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	8.69e-06	0.000229	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—CYP1B1—glaucoma	8.59e-06	0.000226	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—ABCA1—glaucoma	8.59e-06	0.000226	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—APOE—glaucoma	8.12e-06	0.000214	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—CAV1—glaucoma	8.05e-06	0.000212	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—GSTM1—glaucoma	8.04e-06	0.000212	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—MTHFR—glaucoma	7.1e-06	0.000187	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—GSTM1—glaucoma	6.87e-06	0.000181	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—APOE—glaucoma	6.61e-06	0.000174	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—CAV1—glaucoma	6.55e-06	0.000173	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—NOS3—glaucoma	6.09e-06	0.00016	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—MTHFR—glaucoma	6.07e-06	0.00016	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—APOE—glaucoma	5.65e-06	0.000149	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—CAV1—glaucoma	5.6e-06	0.000148	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—PTGS2—glaucoma	5.57e-06	0.000147	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—NOS3—glaucoma	4.95e-06	0.000131	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—PTGS2—glaucoma	4.53e-06	0.000119	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—NOS3—glaucoma	4.23e-06	0.000112	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—PTGS2—glaucoma	3.87e-06	0.000102	CbGpPWpGaD
